Panagora Asset Management Inc Altimmune, Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$8.43 - $16.81 $1,028 - $2,050	-122 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$7.84 - $14.22 $956 - $1,734	122 New	122 $1,000
Q2 2020 Aug 12, 2020	SELL	$2.9 - $10.71 $2,929 - $10,817	-1,010 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.53 - $2.15 $1,545 - $2,171	1,010 New	1,010 $2,000

208

39.5M

1.94M

1.38M

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $315M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.